Written from the studies on PubMed, searched on 11 Nov 2026. Every number below comes from a study listed under Sources.
What people read
Posts online say that CBD (cannabidiol) helps with Fatty liver disease (MASLD/MASH).
What has been studied
- 0In people
- 3In animals
- 0Only in the lab
What the studies found
CBD (cannabidiol) has been studied for Fatty liver disease (MASLD/MASH) in animals, not yet in people.
We found 5 published papers on CBD (cannabidiol) and Fatty liver disease (MASLD/MASH). They were published between 2019 and 2026.
0 of them are studies in people (0 randomised trials), 1 are reviews, 3 are studies in animals and 0 are studies only in the lab.
The most important ones are listed under Sources.
What this means for you: Results in animals or in cells often do not hold in people. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.
Sources
- The Role of Cannabidiol in Liver Disease: A Systemic Review.2024 · Int J Mol Sci · Review
- Cannabidiolic acid as a modulator of lipid metabolism in the liver of rats with metabolic-associated steatotic liver disease.2026 · Sci Rep · In animals
- The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.2020 · Front Endocrinol (Lausanne) · In animals
- Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high-fat high cholesterol diet via regulating NF-κB and NLRP3 inflammasome pathway.2019 · J Cell Physiol · In animals
- Cannabis and Cannabidiol: Pioneering Treatment for the Nervous System with Alzheimer's Disease and Peripheral Organ Involvement with Nonalcoholic Fatty Liver Disease (NAFLD).2025 · Curr Neurovasc Res · Other paper
